p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading

被引：0
|
作者：
Emanuela Guerra
Alessia Cimadamore
Pasquale Simeone
Giovanna Vacca
Rossano Lattanzio
Gerardo Botti
Valentina Gatta
Marco D’Aurora
Barbara Simionati
Mauro Piantelli
Saverio Alberti
机构：
[1] University of Chieti,Unit of Cancer Pathology, CeSI
[2] University ‘G. D’Annunzio’,MeT
[3] National Cancer Institute,Department of Medical, Oral and Biotechnological Sciences
[4] University ‘G. D’Annunzio’,Department of Pathology “Foundation G.Pascale”
[5] BMR Genomics srl,Department of Psychological, Health ad Territorial Sciences, School of Medicine and Life Sciences
[6] University ‘G. D’Annunzio’,Department of Neurosciences, Imaging and Clinical Sciences
来源：
BMC Cancer | / 16卷
关键词：
Breast cancer; Metastatic relapse; Prognostic indicators; TP53; Bcl-2; Cathepsin D; RAS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Analysis of bcl-2 and p53 genes in patients with breast cancer
    Duenas, A
    Cruz, JJ
    SalazarSaez, R
    Abad, MM
    GonzalezSarmiento, R
    Rodriguez, CA
    Fonseca, E
    Gomez, A
    Martin, G
    Sanchez, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 30 - 30
  • [12] Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: Comparison with traditional clinicopathologic variables
    Erdem, O
    Erdem, M
    Dursun, A
    Akyol, G
    Erdem, A
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2003, 22 (03) : 254 - 260
  • [13] Prognostic implications of p53 and bcl-2 expression in 108 women with stage two breast cancer
    McLaughlin, R
    O'Hanlon, D
    McHale, T
    Connolly, CE
    Given, HF
    IRISH JOURNAL OF MEDICAL SCIENCE, 2001, 170 (01) : 11 - 13
  • [14] Prognostic implications of p53 and bcl-2 expression in 108 women with stage two breast cancer
    R. McLaughlin
    D. O’Hanlon
    T. McHale
    C. E. Connolly
    H. F. Given
    Irish Journal of Medical Science, 2001, 170 : 11 - 13
  • [15] p53 and BCL-2 AS prognostic factors in young patient with colorectal cancer
    Garufi, Carlo
    Mottolese, Marcella
    Torsello, Angela
    Piperno, Giulia
    Calabretta, Francesca
    Zeuli, Massimo
    Cosimelli, Maurizio
    Vanni, Barbara
    Cognetti, Francesco
    Terzoli, Edmondo
    ANNALS OF ONCOLOGY, 2004, 15 : 71 - 71
  • [16] The prognostic significance of the immunohistochemical expression of P53 and BCL-2 in endometrial cancer
    Dobrzycka, Bozena
    Terlikowski, Slawomir J.
    Garbowicz, Magdalena
    Niklinski, Jacek
    Chyczewski, Lech
    Kulikowski, Marek
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2011, 49 (04) : 631 - 635
  • [17] Prognostic factors in resectable pancreatic cancer: p53 and Bcl-2 - Discussion
    Yeo, C
    Bold, R
    Swanson, R
    JOURNAL OF GASTROINTESTINAL SURGERY, 1999, 3 (03) : 276 - 277
  • [18] p53 and BCL-2 as prognostic markers in endometrial carcinoma
    Appel, Marcia L. M.
    Edelweiss, Maria I.
    Fleck, James
    Rivero, Luis F.
    Rivoire, Waldemar A.
    Monego, Heleusa I.
    dos Reis, Ricardo
    PATHOLOGY & ONCOLOGY RESEARCH, 2008, 14 (01) : 23 - 30
  • [19] P53, BCL-2 and drug resistance in cancer
    Therwath, A
    MULTI-DRUG RESISTANCE IN EMERGING AND RE-EMERGING DISEASES, 2000, : 249 - 252
  • [20] MDM2 and BCL-2: to p53 or not to p53?
    Wang, Eunice S.
    BLOOD, 2023, 141 (11) : 1237 - 1238
12345